ANTXR1 (TEM8) overexpression in gastric adenocarcinoma makes the protein a potential target of immunotherapy

ConclusionsOur findings suggest that ANTXR1 is a promising candidate for preclinical and clinical evaluation for gastric adenocarcinoma immunotherapy.

http://link.springer.com/10.1007/s00262-019-02392-y

Source: Cancer Immunology, Immunotherapy - September 13, 2019 Category: Cancer & Oncology Source Type: research